Andrew S. Boyer, Executive Vice President at Amneal Pharmaceuticals, Inc. (AMRX), sold 558,488 shares at $9.38 ($5.2M) on 2025-08-20, disclosed to the SEC on 2025-08-22.
Open-market sale of $5.2M AMRX by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.38 | 279,244 | $2.6M | 50.0% |
| 2 | $9.38 | 279,244 | $2.6M | 50.0% |
| Total | $9.38 avg | 558,488 | $5.2M | 100% |
| Filing → |
| AMRX | SELL | 2024-08-16 | $983K | — | Filing → |
| AMRX | SELL | 2023-08-15 | $242K | — | Filing → |
| AMRX | BUY | 2019-08-07 | $385K | — | Filing → |